Information Library
Thought leadership
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Shaping Clinical Transformation
November 18, 2009
A summary of key insights exchanged between pharma executives at the inaugural Quintiles Consulting Executive Vision Forum. -
Drug Information Association (DIA) US 2010
June 13 - June 16, 2010
Exhibit Dates: June 13 - 16, 2010 Exhibitor Booth Number: 1035 Quintiles Speakers: TBD -
ASCO 2010 Annual Meeting
June 4 - June 8, 2010
Exhibit Dates: June 5 - 7, 2010 Exhibitor Booth Number: 2053 -
CRO Partnerships 2010
April 12 - April 14, 2010
19th Annual Partnerships with CROs conference -
Enhancing a Culture of Safety in the Life Sciences Sector
October 6, 2009
Axel Olsen, Executive Director of Global Pharmacovigilance and Risk Management, stresses that stakeholder collaboration is the key to improving drug safety. -
Rewarding Innovation and Value: What is the Role of Comparative Effectiveness Research
October 6, 2009
The impact of comparative effectiveness research on the future of drug development. -
Comparative Effectiveness Research as a Drug Development Tool
September 1, 2009
A Q&A with John Doyle, Vice President and Practice Leader of Quintiles Consulting, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development. -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Charting a New Course by Catalyzing Transformation
June 9, 2009
Adrian McKemey, Quintiles Consulting Product Development and Commercialization Practice Leader, and Michael Arlotto, Senior Vice President Corporate Development Quintiles, discuss how organizations are transforming their clinical organizations to more effectively deliver safer drugs. -
Rebalancing Risk to Transform R&D
June 3, 2009
A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource.